4//SEC Filing
Hillan Kenneth J. 4
Accession 0001209191-23-035076
CIK 0001804591other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:20 PM ET
Size
7.4 KB
Accession
0001209191-23-035076
Insider Transaction Report
Form 4
Hillan Kenneth
Head of Therapeutics
Transactions
- Tax Payment
Class A Common Stock
2023-06-05$2.08/sh−15,347$31,922→ 221,876 total - Award
Class A Common Stock
2023-06-05+44,381→ 237,223 total
Footnotes (2)
- [F1]Restricted stock units (the "RSUs") granted under the 23andMe Amended and Restated Annual Incentive Plan and the 23andMe Holding Co. 2021 Incentive Equity Plan (together, the "Plans") as payment of the reporting person's annual incentive bonus for the fiscal year ended March 31, 2023. The RSUs are fully vested at the time of grant and are subject to the terms and conditions of the Plans, the applicable award agreement, and applicable tax withholding obligations. Each RSU represents the contingent right to receive one share of Class A common stock of 23andMe Holding Co.
- [F2]The closing price on June 5, 2023, the fair market value used for the transaction date.
Documents
Issuer
23andMe Holding Co.
CIK 0001804591
Entity typeother
Related Parties
1- filerCIK 0001600359
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:20 PM ET
- Size
- 7.4 KB